directCHECK ACT-LR whole blood quality control: recall status
Notice names this product. Accriva Diagnostics’s directCHECK ACT-LR whole blood quality control is named in FDA Class II recall Z-2460-2026.
Your particular item is not yet verified. Compare the identifiers and exclusions in the notice before deciding whether it applies.Agency-reported hazard: Assayed Whole blood control contains labeling with incorrect performance range. Identifying details: Lot #: A6DLA001 Unique Device Identifier: 10711234170373. Units affected: 6,060. Status: Ongoing.
1. Compare your item
This notice names a product; your particular item is not yet verified. Compare every applicable model, serial, lot, production-date or model-year boundary below.
Product named
directCHECK ACT-LR whole blood quality control
Company / brand
Accriva Diagnostics
Lot / serial / date codes
Lot #: A6DLA001 Unique Device Identifier: 10711234170373
Distribution
Worldwide - US Nationwide distribution including in the states of AL, AR, AZ, CA, FL, GA, ID, IL, IN, KY, MA, MD, MI, MN, MO, MT, NC, NJ, NM, NY, OH, OK, PA, SC, TN, TX, VA, VT, WA, WI, WV and the countries of Canada, Hong Kong, Spain.
Still to verify: match the label on your item with the full official notice, including any exclusions, tables and photos. Some identifiers appear only on the agency website and are absent from this data feed. A missing field does not mean all versions are affected.
If your lot or date falls outside a stated range, this notice has not established that your item is affected. This is not a finding about other recalls or product safety.